Form 4: Alignment Healthcare Exec Sells Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Dawn Christine Maroney, President of Alignment Healthcare, Inc., reported transactions involving the sale and gifting of common stock.

Summary

  • Dawn Christine Maroney, President of Alignment Healthcare, Inc., reported the sale of 30,000 shares of common stock on May 15, 2026, at a weighted-average price of $16.0855.
  • Following this sale, Maroney's beneficial ownership of common stock decreased.
  • Additionally, Maroney reported gifts of 1,500 shares on May 15, 2026, and 20,000 shares on May 18, 2026, to a family member and a charitable donor-advised fund, respectively.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the sale of a significant number of shares by a key executive, although it was conducted under a pre-arranged trading plan.

Negatives

  • President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare common stock.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The sale of shares by a corporate officer, especially under a Rule 10b5-1 plan, is a common event but is closely watched by investors for potential signals about management's confidence in the company's future prospects.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Rule 10b5-1 PlanTransaction made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).05/22/2025Indicates pre-planned trading activity, potentially mitigating concerns about insider trading based on non-public information.

Related Party Transactions

  • Gift of 1,500 shares to a family member on May 15, 2026.
  • Gift of 20,000 shares to a charitable donor advised fund on May 18, 2026.

Stakeholder Impact

  • Shareholders may view the sale of shares by the President with caution, although the transaction was executed under a Rule 10b5-1 plan.
  • The gifting of shares to a family member and a charity represents a personal disposition of assets.

Key Dates

DateDescription
05/22/2025Date of Rule 10b5-1 plan adoption.
05/15/2026Earliest transaction date reported; sale of 30,000 shares and gift of 1,500 shares.
05/18/2026Gift of 20,000 shares.
05/19/2026Date of signature for the filing.

Recommendation

hold

The sale of shares by a key executive, even under a 10b5-1 plan, warrants a cautious 'hold' recommendation. While the plan suggests pre-determined trading, significant insider selling can sometimes precede negative news or indicate a lack of confidence in near-term stock appreciation. Further analysis of the company's fundamentals and the executive's overall holdings is recommended.

Keywords

Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Beneficial Ownership, Dawn Christine Maroney, President

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.